Cited by 180Mitochondrial Function and PathologyHereditary Neurological DisordersParkinson's Disease Mechanisms and Treatments

The role of mitochondria in inherited neurodegenerative diseases

Kwong, Jennifer Q., Beal, M. Flint, Manfredi, Giovanni·2006·Journal of Neurochemistry

Abstract

In the past decade, the genetic causes underlying familial forms of many neurodegenerative disorders, such as Huntington's disease, Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Friedreich ataxia, hereditary spastic paraplegia, dominant optic atrophy, Charcot‐Marie‐Tooth type 2A, neuropathy ataxia and retinitis pigmentosa, and Leber's hereditary optic atrophy have been elucidated. However, the common pathogenic mechanisms of neuronal death are still largely unknown. Recently, mitochondrial dysfunction has emerged as a potential ‘lowest common denominator’ linking these disorders. In this review, we discuss the body of evidence supporting the role of mitochondria in the pathogenesis of hereditary neurodegenerative diseases. We summarize the principal features of genetic diseases caused by abnormalities of mitochondrial proteins encoded by the mitochondrial or the nuclear genomes. We then address genetic diseases where mutant proteins are localized in multiple cell compartments, including mitochondria and where mitochondrial defects are likely to be directly caused by the mutant proteins. Finally, we describe examples of neurodegenerative disorders where mitochondrial dysfunction may be ‘secondary’ and probably concomitant with degenerative events in other cell organelles, but may still play an important role in the neuronal decay. Understanding the contribution of mitochondrial dysfunction to neurodegeneration and its pathophysiological basis will significantly impact our ability to develop more effective therapies for neurodegenerative diseases.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2006.03990.x

Cites

202 of 202 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pathogenic mutations in several genes including α-synuclein, parkin, UCHL-1, DJ-1, PINK-1, LRRK-2, NURR-1, tau, and HtrA2 directly or indirectly implicate a role of mitochondrial dysfunction in familial PD pathogenesis.

    “In addition to mtDNA mutations, pathogenic mutations in several genes including α–synuclein, parkin, UCHL-1, DJ-1, PINK-1, LRRK-2, NURR-1, tau, and HtrA2 also directly or indirectly implicate a role of mitochondrial dysfunction in familial PD pathogenesis3, 28, 29.”

    From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [3]

  • Mitochondrial dysfunction plays a role in the pathophysiology of Parkinson's disease.

    “Much evidence suggests a role for mitochondrial dysfunction in the pathophysiology of PD, a common age-associated neurodegenerative disease characterized by progressive degeneration of the nigrostriatal dopamine (DA) pathway and presence of the intraneuronal protein inclusions (Lewy bodies)1-3.”

    From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [3]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kwong, J. Q., Beal, M. F., & Manfredi, G.
Affiliations
Cornell University (US)
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2006-06
Volume
97
Issue
6
Pages
1659-1675
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2007815419
Cited by
180
References
202
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 5 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 12 · 2014: 9 · 2013: 15 · 2012: 9
FWCI
1.64
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Neurological Disorders and Stroke (P01NS011766)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
mitochondria, mitochondrial dysfunction, inherited neurodegenerative disorders, neuronal cell death, Huntington's disease, Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Friedreich's ataxia, hereditary spastic paraplegia, autosomal dominant optic atrophy, Charcot-Marie-Tooth disease type 2A, mitochondrial DNA mutations, nuclear-encoded mitochondrial proteins, pathogenesis
MeSH terms
Animals, Humans, Mitochondria, Heredodegenerative Disorders, Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review